Use access key #2 to skip to page content.
$45.16 -3.92 (-7.99%)
12/1/2008 3:59 PM

SPDR S&P Biotech (ETF) (XBI)

CAPS Rating:
***

Exchange traded funds

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating XBI

Add Stock to Watchlist

What the Community Thinks

Total Members

61 Outperforms
5 Underperforms
 

All-Stars

10 Outperforms
3 Underperforms
 

Members bullish on XBI are also bullish on:

Members bearish on XBI are also bearish on:

Ticker Tags

ETF (Exchange Traded Fund or Note) (966), Capital Markets (1153), Small Cap (1449)
Suggest a tag

SPDR S&P Biotech (ETF) At A Glance

Current Price: $45.16
Last Trade Time: 12/1/2008 3:59 PM
Open: $0.00
Previous Close: $49.08
Daily Range: $45.08 - $48.15
52-Week Range: $43.03 - $69.50
Volume: 154,507
Market Cap: $509.10M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

XBI VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 8 :   1 2 Next »

Recs

0

 (XBI)

Avatar cubanstockpicker (78.70) Submitted: 11/22/08 6:33 PM : Outperform Start Price: $46.00 XBI Score: -1.80

52 week low and getting on thanks to etf innovators.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XBI)

Avatar richardrogers4 (68.60) Submitted: 8/30/08 12:52 PM : Outperform Start Price: $64.56 XBI Score: 6.85

Should continue to do well regardless of the economy.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XBI)

Avatar mpor43 (< 20) Submitted: 8/01/08 7:06 PM : Outperform Start Price: $67.35 XBI Score: 1.93

Boitech is entering a bull market phase

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XBI)

Avatar hansthered0 (< 20) Submitted: 6/16/08 5:42 PM : Outperform Start Price: $58.89 XBI Score: 16.72

BIOTECH

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XBI)

Avatar jcder (54.83) Submitted: 2/19/08 5:31 PM : Outperform Start Price: $54.73 XBI Score: 21.23

Biotech should be less susceptible to recession overall. This industry is focused on new ideas that will create new avenues to profit.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 8 :   1 2 Next »

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links